Your browser doesn't support javascript.
loading
Risk factors of severe COVID-19 in people with multiple sclerosis : A systematic review and meta-analysis.
Etemadifar, M; Nouri, H; Maracy, M R; Akhavan Sigari, A; Salari, M; Blanco, Y; Sepúlveda, M; Zabalza, A; Mahdavi, S; Baratian, M; Sedaghat, N.
Afiliación
  • Etemadifar M; Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Nouri H; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran; Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, Iran.
  • Maracy MR; Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Akhavan Sigari A; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Salari M; Department of Neurology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Blanco Y; Center of Neuroimmunology and Service of Neurology, August Pi Sunyer Institute of Biomedical Research, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Sepúlveda M; Center of Neuroimmunology and Service of Neurology, August Pi Sunyer Institute of Biomedical Research, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Zabalza A; Servei de Neurologia-Neuroimmunologia, Departament de Medicina, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Mahdavi S; Clinical Research Development Center, Islamic Azad University of Najafabad, Isfahan, Iran.
  • Baratian M; Clinical Research Development Center, Islamic Azad University of Najafabad, Isfahan, Iran.
  • Sedaghat N; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran; Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, Iran. Electronic address: nahad.sedaghat@gmail
Rev Neurol (Paris) ; 178(1-2): 121-128, 2022.
Article en En | MEDLINE | ID: mdl-34836608
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Aged / Humans / Male Idioma: En Revista: Rev Neurol (Paris) Año: 2022 Tipo del documento: Article País de afiliación: Irán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Aged / Humans / Male Idioma: En Revista: Rev Neurol (Paris) Año: 2022 Tipo del documento: Article País de afiliación: Irán